A review on drug safety, regulation and factors affecting the drug safety and efficacy
نویسندگان
چکیده
منابع مشابه
Nurses’ Perspectives on Factors Affecting Patient Safety: A Qualitative Study
Patient safety is a global concern that involves all healthcare members, so that achieving a high level safe care is responsibility of all healthcare services, particularly nurses. This qualitative study aimed to describe nurses’ perspectives on factors affecting patient safety. We recruited 32 nurses working in teaching hospitals by purposeful sampling method. Data were collected by semi-struc...
متن کاملDrug-review deadlines and safety problems.
BACKGROUND The Prescription Drug User Fee Act (PDUFA) imposes deadlines for the completion of drug reviews by the Food and Drug Administration (FDA). Critics have suggested that these deadlines may result in rushed approvals and the emergence of unanticipated safety problems once a product is in clinical use. METHODS We assessed the association between the PDUFA deadlines and the timing of FD...
متن کاملThe safety and efficacy of new drug approval.
The perception that agencies are out of control arises from the fact that in being called on to make fundamental value judgments they have moved outside their accustomed sphere of activity, outside their expertise, and outside the established system of controls. This perturbation ofthe regulatory process will not be corrected until the agencies are relieved of the necessity of makingjudgments t...
متن کاملEfficacy and safety of the weight-loss drug rimonabant.
1 Quebec Heart Institute, Laval Hospital Research Center, Laval University, Sainte-Foy, Quebec G1V 4G5, Canada ; 2 Department of Diabetology, Metabolism, and Clinical Nutrition, University Hospital Antwerp, Faculty of Medicine (Department of Diabetology, Metabolism, and Clinical Nutrition), Edegem-Antwerp, Belgium ; 3 St Luke's-Roosevelt Hospital Center, New York, NY, USA; 4 Division of Diabete...
متن کاملClinical Trials in the Assessment of Drug Efficacy and Safety.
NEW drugs must be tried out adequately in two or more unrelated animal species before the compound is administered to man (Noel, 1962). The extent of such testing depends on the proposed duration of clinical use. In man the phases of introduction of new compounds may be divided into three: 1. initial human administration; 2. clinical trial to assess efficacy; 3. general medical use. The amount ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Advance Pharmaceutical Journal
سال: 2020
ISSN: 2456-1436
DOI: 10.31024/apj.2020.5.6.3